Complement activation products C5a and sC5b-9 are associated with low-grade inflammation and endothelial dysfunction, but not with atherosclerosis in a cross-sectional analysis: The CODAM study

E. Hertle*, M.M.J. van Greevenbroek, I.C.W. Arts, C.J.H. van der Kallen, E.J.M. Feskens, C.G. Schalkwijk, C.D.A. Stehouwer

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)400-403
JournalInternational Journal of Cardiology
Issue number2
Publication statusPublished - 1 Jan 2014

Cite this